ZA9810637B - Formulations comprising dissolved paroxetine. - Google Patents

Formulations comprising dissolved paroxetine.

Info

Publication number
ZA9810637B
ZA9810637B ZA9810637A ZA9810637A ZA9810637B ZA 9810637 B ZA9810637 B ZA 9810637B ZA 9810637 A ZA9810637 A ZA 9810637A ZA 9810637 A ZA9810637 A ZA 9810637A ZA 9810637 B ZA9810637 B ZA 9810637B
Authority
ZA
South Africa
Prior art keywords
formulations
paroxetine
dissolved
dissolved paroxetine
Prior art date
Application number
ZA9810637A
Other languages
English (en)
Inventor
Graham Stanley Leonard
Ahmad Ghazawi
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA9810637B publication Critical patent/ZA9810637B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9810637A 1997-11-21 1998-11-20 Formulations comprising dissolved paroxetine. ZA9810637B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9724544.3A GB9724544D0 (en) 1997-11-21 1997-11-21 Novel Formulation

Publications (1)

Publication Number Publication Date
ZA9810637B true ZA9810637B (en) 2000-05-22

Family

ID=10822374

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9810637A ZA9810637B (en) 1997-11-21 1998-11-20 Formulations comprising dissolved paroxetine.

Country Status (24)

Country Link
EP (1) EP1033986A1 (pt)
JP (1) JP2001523718A (pt)
KR (1) KR20010032320A (pt)
CN (1) CN1279608A (pt)
AP (1) AP2000001821A0 (pt)
AR (1) AR015485A1 (pt)
AU (1) AU1168099A (pt)
BG (1) BG104527A (pt)
BR (1) BR9814220A (pt)
CO (1) CO4970832A1 (pt)
DZ (1) DZ2658A1 (pt)
EA (1) EA200000552A1 (pt)
GB (1) GB9724544D0 (pt)
HU (1) HUP0100580A3 (pt)
IL (1) IL136106A0 (pt)
MA (1) MA24704A1 (pt)
NO (1) NO20002590L (pt)
OA (1) OA11385A (pt)
PE (1) PE20000381A1 (pt)
PL (1) PL340555A1 (pt)
SK (1) SK7342000A3 (pt)
TR (1) TR200001423T2 (pt)
WO (1) WO1999026625A1 (pt)
ZA (1) ZA9810637B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810180D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulation
EP1161241B1 (de) * 1999-03-12 2005-12-07 Aesica Pharmaceuticals Ltd. Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
DK1109806T3 (da) 1999-07-01 2003-12-22 Italfarmaco Spa Komplekser af paroxetin med cyclodextriner eller cyclodextrinderivater
DE19930454A1 (de) * 1999-07-02 2001-01-04 Knoll Ag Feste Paroxetin enthaltende Zubereitungen
US6720003B2 (en) 2001-02-16 2004-04-13 Andrx Corporation Serotonin reuptake inhibitor formulations
ES2294197T3 (es) * 2001-12-21 2008-04-01 Supernus Pharmaceuticals, Inc. Formulacion de capsula oral con estabilidad fisica aumentada.
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
WO2006119779A2 (en) * 2005-05-10 2006-11-16 Lifecycle Pharma A/S A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution
JP2013512948A (ja) * 2009-12-08 2013-04-18 イル・ファ・カンパニー・リミテッド ２０−Ｏ−β−Ｄ−グルコピラノシル−２０（Ｓ）−プロトパナキサジオールを含む固体分散体
GB201020032D0 (en) * 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9707585A (es) * 1995-04-03 1997-12-31 Abbott Lab Mezclas homogeneas de farmacos y aditivos de fusion a baja temperatura para liberacion controlada.
NZ336587A (en) * 1997-01-15 2001-01-26 Smithkline Beecham P Spray dried paroxetine compositions using organic solvent selected from pyridine, acetic acid, acetonitrile, acetone, ethanol, propan-1-ol or tetrahydrofuran

Also Published As

Publication number Publication date
WO1999026625A1 (en) 1999-06-03
BG104527A (en) 2001-04-30
CO4970832A1 (es) 2000-11-07
HUP0100580A2 (hu) 2002-04-29
AR015485A1 (es) 2001-05-02
NO20002590L (no) 2000-07-19
TR200001423T2 (tr) 2000-10-23
SK7342000A3 (en) 2000-12-11
PL340555A1 (en) 2001-02-12
EA200000552A1 (ru) 2000-10-30
KR20010032320A (ko) 2001-04-16
EP1033986A1 (en) 2000-09-13
HUP0100580A3 (en) 2002-05-28
DZ2658A1 (fr) 2003-03-22
OA11385A (en) 2004-01-27
BR9814220A (pt) 2001-12-26
AP2000001821A0 (en) 2000-06-30
CN1279608A (zh) 2001-01-10
GB9724544D0 (en) 1998-01-21
IL136106A0 (en) 2001-05-20
AU1168099A (en) 1999-06-15
PE20000381A1 (es) 2000-05-07
JP2001523718A (ja) 2001-11-27
NO20002590D0 (no) 2000-05-19
MA24704A1 (fr) 1999-07-01

Similar Documents

Publication Publication Date Title
ZA993338B (en) Pharmaceutical formulations.
ZA982253B (en) Therapeutic compositions.
ZA993938B (en) Ziprasidone formulations.
ZA984849B (en) Compositions.
GB9715751D0 (en) Formulations
ZA9811849B (en) Vaccine.
ZA984969B (en) Vaccine.
ZA988789B (en) Vaccine.
PL343021A1 (en) Formulations
ZA976777B (en) Anthelmintic formulations.
MXPA02001088A (es) 2-pirazolin-5-onas..
HK1027957A1 (en) Pharmaceutical composition.
ZA981029B (en) Pharmaceutical agents.
MXPA01012478A (es) Formulaciones farmaceuticas mejoradas.
ZA989680B (en) Pharmaceutical composition.
ZA9810637B (en) Formulations comprising dissolved paroxetine.
HK1022853A1 (en) Pharmaceutical compositions.
HK1040488A1 (en) Pharmaceutical formulations.
ZA987392B (en) Pharmaceutical composition.
AU134029S (en) Tillage point
ZA200005697B (en) Paroxetine compositions.
ZA99890B (en) Pharmaceutical compositions.
AU134028S (en) Tillage point
ZA988206B (en) Piperidinylmethyloxazolidinone derivative.
GB9815001D0 (en) Formulations